Diagnosis of JAK2 mutated polycythemia vera requires both of the following 2 criteria to be present: 1) high hematocrit (>0.52 in men, >0.48 in women) or raised red cell mass (>25% above predicted); 2) mutation in JAK2, i.e., JAK2 (V617F) or mutation of exon 12. These criteria are very similar to the major criteria of the WHO classification, which considers hemoglobin level (>18.5 g/dL in men, >16.5 g/dL in women, or other evidence of increased red cell mass) instead of hematocrit. The only difference is that the WHO classification requires, in addition to the two major criteria, at least one minor criterion (bone marrow biopsy showing hypercellularity, serum erythropoietin below the normal range, or endogenous erythroid colony formation in vitro).
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Supplemental Methods
Diagnosis of JAK2 mutated polycythemia vera according to the criteria of the British Committee for Standards in Hematology
Diagnosis of JAK2 mutated polycythemia vera requires both of the following 2 criteria to be present: 1) high hematocrit (>0.52 in men, >0.48 in women) or raised red cell mass (>25% above predicted); 2) mutation in JAK2, i.e., JAK2 (V617F) or mutation of exon 12. These criteria are very similar to the major criteria of the WHO classification, which considers hemoglobin level (>18.5 g/dL in men, >16.5 g/dL in women, or other evidence of increased red cell mass) instead of hematocrit. The only difference is that the WHO classification requires, in addition to the two major criteria, at least one minor criterion (bone marrow biopsy showing hypercellularity, serum erythropoietin below the normal range, or endogenous erythroid colony formation in vitro).
In order to assess polycythemic transformation of essential thrombocythemia, we adopted the criteria of the British Committee for Standards in Hematology since sequential evaluations of bone marrow biopsy were not available in most patients.
Sanger sequencing of CALR exon 9
The following M13--tagged primers were used for PCR --Forward 5'--tgtaaaacgacggccagtAAGCAAGGGCTATCGGGTAT--3' --Reverse 5'--caggaaacagctatgaccAACCAAAATCCACCCCAAAT--3'
and for sequencing --Forward 5'--TGTAAAACGACGGCCAGT--3'. AAEKQMKDKQDEEQRLKEEEEDKKRKEEEEAEDKEDDEDKDEDEEDEEDKEEDEEEDVPGQAKDEL--* The aminoacid sequence starting from codon A352 is reported. Acid and basic residues are in red and blue, respectively.
Supplemental
